1.
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
by Ettehad, Dena, MSc
The Lancet (British edition), 2015, Vol.387 (10022), p.957-967

2.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443

3.
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
by Chow, Clara K, Prof
The Lancet (British edition), 2017, Vol.389 (10073), p.1035-1042

4.
Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study
by Rådholm, Karin
Age and ageing, 2015-05, Vol.44 (3), p.422-427

5.
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studie...
by Guo, Rui
Neurosurgery, 2017-12-01, Vol.81 (6), p.980-985

6.
Trials on blood pressure–lowering and secondary stroke prevention
by Chalmers, John
The American journal of cardiology, 2003, Vol.91 (10), p.3-8

7.
Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2
by Sato, Shoichiro
Journal of neurology, neurosurgery and psychiatry, 2015-12, Vol.86 (12), p.1319-1323

8.
Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study
by Muñoz Venturelli, Paula
Age and ageing, 2017-03-01, Vol.46 (2), p.329-332

9.
Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial
by Sato, Shoichiro
Cerebrovascular diseases (Basel, Switzerland), 2015-09, Vol.40 (3-4), p.114-120

10.
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease:...
by Chalmers, John
Hypertension (Dallas, Tex. 1979), 2014-02, Vol.63 (2), p.259-264

11.
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight and obese individuals: the PROGRESS Trial
by Czernichow, Sébastien Sébastien
Hypertension (Dallas, Tex. 1979), 2010-03-08, Vol.55 (5), p.1193-1198

12.
An Economic Evaluation of a Perindopril-Based Blood Pressure Lowering Regimen for Patients Who Have Suffered a Cerebrovascular Event
by Tavakoli, Manouchehr
The European journal of health economics, 2009-02-01, Vol.10 (1), p.111-119

13.
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
by Copland, Emma
The lancet oncology, 2021-04, Vol.22 (4), p.558-570

14.
Altered c-fos in Rostral Medulla and Spinal Cord of Spontaneously Hypertensive Rats
by Minson, Jane
Hypertension (Dallas, Tex. 1979), 1996-03, Vol.27 (3), p.433-441

15.
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial
by Joshi, Rohina
Expert review of endocrinology & metabolism, 2009-03-01, Vol.4 (2), p.111-118

16.
Blood Pressure Lowering for the Secondary Prevention of Myocardial Infarction and Stroke
by MacMahon, Stephen
Hypertension (Dallas, Tex. 1979), 1997-02, Vol.29 (2), p.537-538

17.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
by HARRAP, Stephen B
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (3), p.297-303

18.
The lowering of blood pressure after stroke
by MacMahon, Stephen
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1994-1995

19.
Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
by Czernichow, Sébastien
Hypertension (Dallas, Tex. 1979), 2010-05, Vol.55 (5), p.1193-1198

20.
The lowering of blood pressure after stroke
by Cates, Christopher
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1993-1993
